Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1186 studies found for:    Open Studies | "Rectal Diseases"
Show Display Options
Rank Status Study
21 Recruiting Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
Conditions: Rectal Cancer;   Rectal Adenocarcinoma
Interventions: Drug: Lenvatinib;   Drug: Capecitabine;   Radiation: External Radiation Therapy (XRT)
22 Recruiting Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Irinotecan;   Drug: Folinic Acid;   Drug: 5-FU;   Drug: Cetuximab;   Drug: Bevacizumab;   Drug: Capecitabine;   Drug: regorafenib;   Drug: Irinotecan 125mg;   Drug: Cetuximab wkly
23 Recruiting Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Recurrent Oncogenic RAS Exon 2 Mutant Rectal Cancer
Condition: Rectal Cancer
Interventions: Biological: TG02-treatment;   Drug: Pembrolizumab
24 Not yet recruiting Opt-In Versus Opt-Out for Colorectal Cancer Screening Outreach
Condition: Cancer of the Colon
Interventions: Behavioral: Opt-In Outreach;   Behavioral: Opt-Out Outreach
25 Recruiting Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Condition: BRAF V600E-mutant Metastatic Colorectal Cancer
Interventions: Drug: Encorafenib;   Drug: Binimetinib;   Drug: Cetuximab;   Drug: Irinotecan;   Drug: Folinic Acid;   Drug: 5-Fluorouracil
26 Recruiting Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer
Conditions: Colorectal Neoplasms;   Aberrant DNA Methylation
27 Not yet recruiting Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer
Conditions: Advanced Colorectal Cancer;   Traditional Chinese Medicine
Interventions: Other: Traditional Chinese medicine herbals;   Other: Integrated traditional Chinese and Western medicine;   Other: Western medicine
28 Recruiting Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Conditions: Rectal Adenocarcinoma;   Stage II Rectal Cancer;   Stage III Rectal Cancer
Interventions: Drug: Capecitabine;   Drug: Fluorouracil;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin;   Drug: Veliparib
29 Not yet recruiting Pembrolizumab in Refractory Metastatic Anal Cancer
Condition: Anal Cancer
Intervention: Drug: Pembrolizumab
30 Recruiting Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer
Condition: Rectal Adenocarcinoma
Interventions: Drug: Gemcitabine;   Radiation: XRT;   Drug: capecitabine
31 Recruiting A Study of MCLA-128 in Patients With Solid Tumors
Conditions: Malignant Solid Tumour;   Breast Cancer;   Colorectal Cancer
Intervention: Drug: MCLA-128
32 Not yet recruiting Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer
Condition: Rectal Cancer
Interventions: Drug: Regorafenib;   Drug: Capecitabine;   Radiation: Radiotherapy;   Procedure: Surgery
33 Not yet recruiting Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer
Conditions: Chemotherapy-induced Nausea and Vomiting;   Colorectal Cancer
Interventions: Drug: Aprepitant+Tropisetron;   Drug: Dexamethasone+Tropisetron
34 Recruiting Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Radiation: Stereotactic body radiotherapy
35 Not yet recruiting Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Conditions: Rectal Cancer;   Anastomotic Leak
Intervention: Device: LifeSeal™ Kit
36 Recruiting Circulating Tumor Material in Colorectal Cancer and Melanoma
Condition: Colorectal Cancer and Melanoma
Intervention: Other: blood collection
37 Recruiting Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Conditions: Breast Cancer;   Lung Cancer;   Colorectal Cancer;   Melanoma;   Gynecological Cancer;   Genitourinary Cancer;   Pancreatobiliary Cancer;   Gastrointestinal Cancer;   Head and Neck Cancer;   Rare Cancer;   Unknown Primary Cancer
38 Not yet recruiting Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: AZD1775;   Drug: Irinotecan
39 Recruiting Transanual Tube Placement in Low Anterior Resection (LAR) for Rectal Cancer
Condition: Rectal Cancer
Intervention: Device: transanual tube placement
40 Recruiting Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients
Condition: Elderly Metastatic Colorectal Cancer Patients
Interventions: Drug: 5-fluorouracil;   Drug: oxaliplatin;   Drug: l-leucovorin;   Drug: panitumumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years